| | |
| | |
Stat |
Members: 3645 Articles: 2'500'096 Articles rated: 2609
18 April 2024 |
|
| | | |
|
Article overview
| |
|
Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension | M Uehata
; T Ishizaki
; H Satoh
; T Ono
; T Kawahara
; T Morishita
; H Tamakawa
; K Yamagami
; J Inui
; M Maekawa
; S Narumiya
; | Date: |
30 Oct 1997 | Journal: | Nature, 389 (6654), 990-4 | Abstract: | Abnormal smooth-muscle contractility may be a major cause of disease states such as hypertension, and a smooth-muscle relaxant that modulates this process would be useful therapeutically. Smooth-muscle contraction is regulated by the cytosolic Ca2+ concentration and by the Ca2+ sensitivity of myofilaments: the former activates myosin light-chain kinase and the latter is achieved partly by inhibition of myosin phosphatase. The small GTPase Rho and its target, Rho-associated kinase, participate in this latter mechanism in vitro, but their participation has not been demonstrated in intact muscles. Here we show that a pyridine derivative, Y-27632, selectively inhibits smooth-muscle contraction by inhibiting Ca2+ sensitization. We identified the Y-27632 target as a Rho-associated protein kinase, p160ROCK. Y-27632 consistently suppresses Rho-induced, p160ROCK-mediated formation of stress fibres in cultured cells and dramatically corrects hypertension in several hypertensive rat models. Our findings indicate that p160ROCK-mediated Ca2+ sensitization is involved in the pathophysiology of hypertension and suggest that compounds that inhibit this process might be useful therapeutically. | Source: | PubMed, pmid9353125 doi: 10.1038/40187 | Services: | Forum | Review | Favorites |
|
|
No review found.
Did you like this article?
Note: answers to reviews or questions about the article must be posted in the forum section.
Authors are not allowed to review their own article. They can use the forum section.
browser claudebot
|
| |
|
|
|
| News, job offers and information for researchers and scientists:
| |